No. of days | LD+T 28 | SD | ANOVA | |||||
---|---|---|---|---|---|---|---|---|

1 | 2 | 4 | 7 | 14 | 28 | |||

HVC | (n = 6) | (n = 7) | (n = 8) | (n = 7) | (n = 7) | (n = 5) | (n = 6) | |

AC-3 cell no. | 836 ± 142^{a} | 1351 ± 309^{a,b} | 1681 ± 222^{b} | 1062 ± 68^{a,b} | 865 ± 91^{a} | 1313 ± 131^{a,b} | 1081 ± 151^{a,b} | F_{(6, 39)}=2.8600, p = 0.0207 |

(n = 9) | (n = 5) | (n = 7) | (n = 8) | (n = 7) | (n = 6) | (n = 7) | ||

BrdU-positive neuron no. | 162 ± 30 | 103 ± 31 | 113 ± 29 | 120 ± 20 | 103 ± 17 | 61 ± 15 | 76 ± 11 | F_{(6,42)}=2.0819, p = 0.0758 |

vVZ | (n = 5) | (n = 5) | (n = 6) | (n = 9) | (n = 5) | (n = 6) | (n = 6) | |

BrdU-positive cell no. | 631 ± 51^{a} | 1116 ± 73^{a,b} | 1680 ± 225^{a,b} | 2246 ± 303^{b} | 1018 ± 235^{a,b} | 893 ± 185^{a,b} | 1187 ± 149^{a,b} | F_{(6,35)}=6.6854, p < 0.0001 |

Coefficient of determination | (n = 6) | (n = 5) | (n = 6) | (n = 8) | (n = 5) | (n = 5) | (n = 4) | |

vVZ proliferation to HVC AC-3 no. | R^{2} = 0.8696,p = 0.0208 | R^{2} = 0.4469,p = 0.1466 | R^{2} = 0.0028,p = 0.9212 | R^{2} = 0.4009,p = 0.5544 | R^{2} = 0.0352,p = 0.8124 | R^{2} = 0.8641,p = 0.2404 | R^{2} = 0.9067,p = 0.0479 |

All values are mean ± SEM.

↵

Denotes significant differences across treatment groups.^{a,b}